|4May 4, 6:14 PM ET

DeLuca Richard R. 4

4 · Merck & Co., Inc. · Filed May 4, 2023

Insider Transaction Report

Form 4
Period: 2023-05-02
DeLuca Richard R.
EVP&Pres, Merck Animal Heallth
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-05-02+44,26044,260 total
    Exercise: $117.89From: 2024-05-02Exp: 2033-05-01Common Stock (44,260 underlying)
Holdings
  • Common Stock

    154,492.854
  • Common Stock - 401(k) Plan

    (indirect: By 401(k))
    1,205.663
Footnotes (1)
  • [F1]The option vests and becomes exercisable in equal installments on 5/2/2024, 5/2/2025 and 5/2/2026.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT